Vaccines

23 May 2017 United Neuroscience Reports Positive Phase 1 Results for Active Vaccine UB-311 in Alzheimer’s Disease
18 May 2017 VAXIMM Announces Data from Phase I Trial in Glioblastoma with Oral T-cell Immunotherapy VXM01 to be Presented at ASCO 2017 Annual Meeting
14 May 2017 Dendreon Announces Results of New PROCEED Registry Analysis Showing Overall Survival Benefit with PROVENGE® in Men with Metastatic Prostate Cancer
11 May 2017 Aimmune Therapeutics Enrolls First Patient in RAMSES (ARC007), a Phase 3 Clinical Trial of AR101 for the Treatment of Peanut Allergy
10 May 2017 Argos Provides Update on its ADAPT Trial Following Meeting with FDA
10 May 2017 EpiThany Announces Clinical Collaboration with Merck KGaA, Darmstadt, Germany, and Pfizer to Evaluate Combination of Avelumab and EP-101 STEMVAC in Breast Cancer
09 May 2017 NantKwest and NantCell Announce FDA Authorization for the NANT Cancer Vaccine Clinical Trials, the First Novel Combination of Innate and Adaptive Immunotherapy in Patients with Pancreatic Cancer
09 May 2017 VAXIMM Announces Collaboration with Merck KGaA, Darmstadt, Germany, and Pfizer to Evaluate Combination of VXM01 with Avelumab in Glioblastoma and Colorectal Cancer in Phase I/II Clinical Studies
08 May 2017 Inovio & Regeneron Enter Immuno-Oncology Clinical Study Agreement for Glioblastoma Combination Therapy
04 May 2017 Hookipa Biotech Presents Positive Data from Phase 1 First-In-Human Trial of Vaccine Against Cytomegalovirus
03 May 2017 VBI Vaccines Provides Update on its Congenital CMV Phase I Clinical Study
03 May 2017 First ever evidence of treatment-induced reduction in HIV reservoirs: ABX464, ABIVAX’ lead drug candidate, impacted HIV blood reservoir in a Phase IIa clinical trial (ABX464-004)
02 May 2017 Yisheng Biopharma Starts Enrollment in Phase 1 Immuno-Oncology Clinical Trial of YS-ON-001 in Patients with Advanced Solid Tumors
24 Apr 2017 Matinas BioPharma Presents Positive Preclinical Data of Orally Available DNA Vaccines at the 27th Annual European Congress of Clinical Microbiology and Infectious Diseases
24 Apr 2017 Inovio Initiates Phase 2 Efficacy Trial with VGX-3100 For HPV-Related Vulvar Pre-Cancers
20 Apr 2017 Targovax initiates first clinical trial with TG02, the second product from its RAS-peptide immunotherapy platform
19 Apr 2017 Bavarian Nordic Announces Initiation of Phase 2 Combination Trial of PROSTVAC, Ipilimumab and Nivolumab in Patients with Localized Prostate Cancer
19 Apr 2017 Vical Completes Target Enrollment in Its Phase 2 Therapeutic HSV-2 Vaccine Trial
19 Apr 2017 Argos Reports Interim Results of the ADAPT Trial and Provides Perspective on Decision to Continue the Trial
18 Apr 2017 Circassia Announces Top-Line Results from House Dust Mite Allergy Field Study
17 Apr 2017 ACARIZAX® approved in Europe for use in adolescent patients with house dust mite-induced allergic rhinitis
11 Apr 2017 Inovio Ebola Vaccine Demonstrates Robust Immune Responses with Favorable Safety Profile in Expanded Clinical Trial
11 Apr 2017 Zika virus: Themis Bioscience initiates worldwide first study with live attenuated recombinant vaccine
06 Apr 2017 Agenus Commences Phase 1 Trial with Neoantigen Cancer Vaccine AutoSynVax
05 Apr 2017 Takeda Completes Enrollment of More Than 20,000 Children and Adolescents in Global Phase 3 Trial of Dengue Vaccine Candidate

La Merie Biologics

FREE Weekly News Bulletin

2016 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Top